References
1. Acute rhinosinusitis: clinical recommendations. In: A.S. Lopatin (ed.). Moscow: Rossiyskoe obshchestvo rinologov, 2017: 36 p. (in Russian)
2. Krivopalov A.A. Rhinosinusitis: classification, epidemiology, etiology and treatment. Meditsinskiy sovet. 2016; 6: 22–5. (in Russian)
3. Fokkens W.J., Lund V.J., Mullol J., Bachert C., Alobid I., Baroody F., Cohen N., Cervin A., Douglas R., Gevaert P., Georgalas C., Goossens H., Harvey R., Hellings P., Hopkins C., Jones N., Joos G., Kalogjera L., Kern B., Kowalski M., Price D., Riechelmann H., Schlosser R., Senior B., Thomas M., Toskala E., Voegels R., Wang de Y., Wormald P.J. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. Asummary for otorhinolaryngologists. Rhinology. 2012; 50 (1): 1–12.
4. Ovchinnikov A.Yu., Edzhe M.A., Khon E.M., Korostelev S.A. Acute rhinosinusitis:the main misconceptions and the possibility of a standard herbal medicine. Meditsinskiy sovet. 2016; 6: 28–31. (in Russian)
5. Ryazantsev S.V., Krivopalov A.A., Eremin S.A., Zakharova G.P., Shabalin V.V., Shamkina P.A., Chufistova A.V. Topical antibacterial therapy for acute rhinosinusitis. RMZh. 2020; 4: 2–7. (in Russian)
6. Kosyakov S.Ya., Minavnina Yu.V. Place of topical steroid therapyin the thretment of acute rhinosinusitis. Meditsinskiy sovet. 2017; 16: 18–23.(in Russian)
7. The principles of etiopathogenesis therapy of acute rhinosinusitis: method. Recommendation. In: S.V. Ryazantsev (ed.). Saint Petersburg: Poliforum Grupp, 2015: 40 p. (in Russian)
8. Karpishchenko S.A., Lavrenova G.V., Shakhnazarov A.E., et al. Acute and chronic rhinosinusitis: additional opportunities of conservative treatment. Folia Otorhinolaryngologiae et Pathologiae Respiratoriae. 2018; 24 (4): 6268. (in Russian)
9. Svistushkin V.M., Nikiforova G.N., Ovchinnikov A.Yu., et al. Opportunities of non-puncture treatment of purulent rhinosinusitis. Rossiyskaya otorinolaringologiya. 2004; 3 (10): 150–2. (in Russian)
10. Referens Vidal’ 2020. Medicines in Russia. Vidal’ Rus, 2020: 1118 p. ISBN:978-5-9500273-9-0. (in Russian)
11. Iwasaki A., Medzhitov R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 2015; 16 (4): 343–53. DOI: 10.1038/ni.3123.
12. Hannoodee S., Nasuruddin D.N. Acute Inflammatory Response. URL: https://www.ncbi.nlm.nih.gov/pubmed/32310543.
13. Koatz A.M., Coe N.A., Cicerán A., Alter A.J. Clinical and immunological benefits of OM-85 bacterial lysate in patients with allergic rhinitis, asthma, and COPD and recurrent respiratory infections. Lung. 2016; 194 (4): 687–97. DOI: 10.1007/s00408-016-9880-5.
14. Esposito S., Bianchini S., Bosis S., Tagliabue C., Coro I., Argentiero A., Principi N. A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the efficacy and safety of OM-85 in children suffering from recurrent respiratory tract infections. J. Transl. Med. 2019; 17 (1): 284. DOI: 10.1186/s12967-019-2040-y.
15. Esposito S., Bianchini S., Polinori I., Principi N. Impact of OM-85 given during two consecutive years to children with a history of recurrent respiratory tract infections: a retrospective study. Int. J. Environ. Res. Public Health. 2019; 16 (6): E1065. DOI: 10.3390/ijerph16061065.
16. Yin M., Zhang Y., Li H. Advances in research on immunoregulation of macrophages by plant polysaccharides. Front. Immunol. 2019; 10: 145. DOI: 10.3389/fimmu.2019.00145.
17. Friedman M. Mushroom polysaccharides: chemistry and antiobesity, antidiabetes, anticancer, and antibiotic properties in cells, rodents, and humans. Foods. 2016; 5 (4): 80.
18. Camilli G., Tabouret G., Quintin J. The complexity of fungal β-glucan in health and disease: effects on the mononuclear phagocyte system. Molecules. 2016; 21 (7): 938.
19. Bashir K.M., Choi J.S. Clinical and physiological perspectives of β-glucans: the past, present, and future. Int. J. Mol. Sci. 2017; 18 (9): 84–102.
20. Jesenak M., Urbancikova I., Banovcin P. Respiratory tract infections and the role of biologically active polysaccharides in their management and prevention. Nutrients. 2017; 9 (7): 779.
21. Elsayed A., Enshasy H., et al. Mushrooms: a potential natural source of anti-inflammatory compounds for medical applications. Mediators Inflamm. 2014; 10 (1): 55–81.
22. Vetvicka V., Vetvickova J. Glucan supplementation enhances the immune response against an influenza challenge in mice. Ann. Transl. Med. 2015; 22 (2): 2305.
23. Muszyńska B., Grzywacz-Kisielewska A., Kała K., Gdula-Argasińska J. Anti-inflammatory properties of edible mushrooms: a review. Food Chem. 2018; 243: 373–81.
24. Leentjens J., Quintin J., Gerretsen J., et al. The effects of orally administered beta-glucan on innate immune responses in humans, a randomized open-label intervention pilot-study. PLoS One. 2014; 9 (9): e108794.
25. Minov J., Bislimovska-Karadzhinska J., et al. Effects of pleuran (Β-glucan from Pleurotus ostreatus) supplementation on incidence and duration of COPD exacerbations. J. Med. Sci. 2017; 5 (7): 893–8.
26. Bezrukova E.V., Vorobeychikov E.V., Konusova V.G. Increment of antibiotic therapy efficiency in acute purulent rhinosinusitis. Rossiyskaya otorinolaringologiya. 2013; 3 (64): 10–6. (in Russian)
27. Bezrukova E.V., Vorobeychikov E.V., Konusova V.G., Kurtser G.M., Simbirtsev A.S. Exploring effect of changing concentration in cytokines IL-1RA and IL-1β of nasal secretions in patients undergoing immune correction to treat chronic polypous rhinosinusitis. Immunologiya. 2019; 40 (5): 5–10.(in Russian)
28. Bezrukova E.V., Vorobeychikov E.V., Konusova V.G., Simbirtsev A.S. Changes of cytokines concentration of IL-1β and IL-1RA in chronic polyposis rhinosinusitis. Meditsinskaya immunologiya. 2019; 21 (6): 1155–62. (in Russian)
29. Patent RF No. 2450812, 20122450812 «Agent for treatment of infectious diseases of respiratory tract «Glyukaferon», 2012. (in Russian)
30. Shamtsyan M.M., Vorobeychikov E.V., Konusova V.G., Simbirtsev A.S. Immunomodulatory properties of higher basidial mushrooms. Tsitokiny i vospalenie. 2012; 11 (1): 26–37. (in Russian)
31. Borovikov V. Statistics: the art of analyzing data on a computer. For professionals. Saint Petersburg: Piter, 2001: 656 p. (in Russian)
32. Subbotina A.V., Grzhibovskiy A.M. Descriptive statistics and validation of the normality of the distribution of quantitative data. Ekologiyacheloveka. 2014; 2: 51–7. (in Russian)
33. van Bruggen R., Drewniak A., Jansen M., et al. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. Mol. Immunol. 2009; 47: 575–81.